Supernus Pharmaceuticals (NASDAQ:SUPN) Lifted to Buy at StockNews.com
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research note released on Wednesday. Separately, Piper Sandler lifted their target price on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a report on Thursday, November 9th. […]
More Stories
Aaron Wealth Advisors LLC Lowers Holdings in Nomura Holdings, Inc. (NYSE:NMR)
Aaron Wealth Advisors LLC lowered its position in shares of Nomura Holdings, Inc. (NYSE:NMR – Free Report) by 7.4% in...
Cadence Design Systems, Inc. (NASDAQ:CDNS) Shares Bought by Stonegate Investment Group LLC
Stonegate Investment Group LLC boosted its stake in shares of Cadence Design Systems, Inc. (NASDAQ:CDNS – Free Report) by 1.3%...
Trust Point Inc. Decreases Stake in Franklin Electric Co., Inc. (NASDAQ:FELE)
Trust Point Inc. reduced its stake in Franklin Electric Co., Inc. (NASDAQ:FELE – Free Report) by 8.6% in the 3rd...
Onto Innovation Inc. (NYSE:ONTO) Shares Sold by Trust Point Inc.
Trust Point Inc. lessened its holdings in shares of Onto Innovation Inc. (NYSE:ONTO – Free Report) by 21.2% during the...
Stonegate Investment Group LLC Cuts Stock Holdings in S&P Global Inc. (NYSE:SPGI)
Stonegate Investment Group LLC cut its stake in S&P Global Inc. (NYSE:SPGI – Free Report) by 8.3% in the third...
Vert Asset Management LLC Acquires 588 Shares of American Tower Co. (NYSE:AMT)
Vert Asset Management LLC increased its stake in American Tower Co. (NYSE:AMT – Free Report) by 0.6% in the 3rd...